← All organizations
Highest phase reached
Phase 2
First clinical trial
Oct 31, 2015Last known activity
Nov 20, 2025
Timeline
No events for the selected filters.
Drugs by trial phase (1 distinct, 10 trials)
Phase 2 (1 own, 0 via acquisition)
Indications
Studied for
Recent trials (10)
- NCT07231484CollaboratorN/ANov 20, 2025
- NCT07214428CollaboratorN/AOct 15, 2025
- NCT06544954CollaboratorN/ASep 30, 2025
- NCT06349304CollaboratorN/AMay 1, 2024
- NCT05972694CollaboratorN/AApr 2, 2024
- NCT05991700CollaboratorPhase 1/Phase 2Jan 31, 2024
- NCT05863507CollaboratorN/AApr 1, 2023
- NCT03741218CollaboratorN/ADec 10, 2018
- NCT03361410CollaboratorPhase 2Nov 18, 2017
- NCT02542176CollaboratorN/AOct 31, 2015
Details
- Last known activity
- Nov 20, 2025